Simon, P.; Petroff, D.; Busse, D.; Heyne, J.; Girrbach, F.; Dietrich, A.; Kratzer, A.; Zeitlinger, M.; Kloft, C.; Kees, F.;
et al. Meropenem Plasma and Interstitial Soft Tissue Concentrations in Obese and Nonobese Patients—A Controlled Clinical Trial. Antibiotics 2020, 9, 931.
https://doi.org/10.3390/antibiotics9120931
AMA Style
Simon P, Petroff D, Busse D, Heyne J, Girrbach F, Dietrich A, Kratzer A, Zeitlinger M, Kloft C, Kees F,
et al. Meropenem Plasma and Interstitial Soft Tissue Concentrations in Obese and Nonobese Patients—A Controlled Clinical Trial. Antibiotics. 2020; 9(12):931.
https://doi.org/10.3390/antibiotics9120931
Chicago/Turabian Style
Simon, Philipp, David Petroff, David Busse, Jana Heyne, Felix Girrbach, Arne Dietrich, Alexander Kratzer, Markus Zeitlinger, Charlotte Kloft, Frieder Kees,
and et al. 2020. "Meropenem Plasma and Interstitial Soft Tissue Concentrations in Obese and Nonobese Patients—A Controlled Clinical Trial" Antibiotics 9, no. 12: 931.
https://doi.org/10.3390/antibiotics9120931
APA Style
Simon, P., Petroff, D., Busse, D., Heyne, J., Girrbach, F., Dietrich, A., Kratzer, A., Zeitlinger, M., Kloft, C., Kees, F., Wrigge, H., & Dorn, C.
(2020). Meropenem Plasma and Interstitial Soft Tissue Concentrations in Obese and Nonobese Patients—A Controlled Clinical Trial. Antibiotics, 9(12), 931.
https://doi.org/10.3390/antibiotics9120931